Related Experiment Video

Updated: Mar 17, 2026

Laboratory Scale Production and Purification of a Therapeutic Antibody
09:54

Laboratory Scale Production and Purification of a Therapeutic Antibody

Published on: January 24, 2017

18.5K

Clinical trials for new antibody

    Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
    |July 15, 2016
    PubMed

    Insights

    Clinical trials are evaluating a new monoclonal antibody for treating myasthenia gravis. This research offers potential new therapeutic options for this debilitating muscle disease.

    Area of Science:

    • Neurology
    • Immunology
    • Pharmacology

    Background:

    • Myasthenia gravis is a chronic autoimmune neuromuscular disease.
    • Current treatments for myasthenia gravis have limitations.
    • Monoclonal antibodies represent a promising therapeutic avenue.

    Purpose of the Study:

    • To evaluate the safety and efficacy of a novel monoclonal antibody.
    • To assess the potential of this antibody as a treatment for myasthenia gravis.

    Main Methods:

    • Clinical trials are currently in progress.
    • The study involves administering the new monoclonal antibody to patients.
    • Patient responses and side effects are being monitored.

    Main Results:

    • Data collection and analysis are ongoing.
    • Preliminary safety and efficacy data are awaited.

    Conclusions:

    • The ongoing clinical trials are crucial for determining the therapeutic value of the new monoclonal antibody.
    • Results will inform future treatment strategies for myasthenia gravis.

    More Related Videos

    Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody07:36

    Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

    Published on: May 16, 2020

    6.0K
    Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety06:37

    Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

    Published on: September 15, 2023

    1.2K

    Related Concept Videos

    Clinical Trials01:16

    Clinical Trials

    Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
    There are four phases in a clinical trial. A phase one...
    11.1K
    Clinical Trials: Overview01:11

    Clinical Trials: Overview

    Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
    5.3K
    Antibody Structure01:10

    Antibody Structure

    Overview
    Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
    The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
    Antibodies consist of four polypeptide chains: two identical heavy...
    67.1K
    Hybridoma Technology01:31

    Hybridoma Technology

    Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
    Hybridoma Selection
    Commonly used fusion techniques — electroporation,...
    18.2K